NCT03842709View on ClinicalTrials.gov

Non-Opioid Pramipexole and Pain

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

February 15, 2021

Conditions
Chronic Pain
Interventions
DRUG

Pramipexole Oral Tablet

Initial dosage of 0.125 mg pramipexole daily, potentially titrated upward in 0.125 increments to a maximum of 0.5 mg daily, for 4 weeks.

OTHER

Placebo

Administration of placebo

Trial Locations (1)

87131

University of New Mexico Hospital, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT03842709 - Non-Opioid Pramipexole and Pain | Biotech Hunter | Biotech Hunter